Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and
monkeypox virus (MPXV) severely threaten human health; however, currently, no vaccine …

In December 2019, a new virus called SARS-CoV-2 was reported in China and quickly
spread to other parts of the world. The development of SARS-COV-2 vaccines has recently …

Multiepitope vaccines could induce multiantigenic immunity against large complex
pathogens with different strain variants. Herein, the in silico, in vitro and in vivo studies were …

Abstract The novel Corona Virus Disease 2019 (COVID-19) pandemic has set the fatality
rates ablaze across the world. So, to combat this disease, we have designed a multi-epitope …

Abstract Background Since the SARS-CoV-2 outbreak in December 2019 in Wuhan, China,
the virus has infected more than 153 million individuals across the world due to its human-to …

Introduction The ongoing life-threatening pandemic of coronavirus disease 2019 (COVID-
19) has extensively affected the world. During this global health crisis, it is fundamentally …

Abstract Background Coronavirus disease 2019 (COVID-19) linked with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) cause severe illness and life-threatening …

Abstract The World Health Organization categorized SARS-CoV-2 as a variant of concern,
having numerous mutations in spike protein, which have been found to evade the effect of …

(1) Background: Many co-infections of Mycobacterium tuberculosis (MTB) and severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) have emerged since the occurrence of …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmittable
and pathogenic human coronavirus that caused a pandemic situation of acute respiratory …